ALPHAMAB-B: (1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED ADOPTION OF THE FIFTH AMENDED AND RESTATED ARTICLES OF

香港交易所 · May 9, 2023 20:03

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.

康寧傑瑞製藥-B：(1) 建議授出購回股份及發行新股的一般授權；(2) 建議重選退任董事；(3) 建議續聘核數師；(4) 建議採納經第五次修訂及重訂組織章程細則；及(5) 股東週年大會通告

ALPHAMAB-B: (1) PROPOSED GRANTING OF GENERAL MANDATES TO REPURCHASE SHARES AND TO ISSUE NEW SHARES; (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS; (3) PROPOSED RE-APPOINTMENT OF AUDITOR; (4) PROPOSED ADOPTION OF THE FIFTH AMENDED AND RESTATED ARTICLES OF

Risk Disclaimer

Statement